Consensus for nonmelanoma skin cancer treatment: basal cell carcinoma, including a cost analysis of treatment methods.

@article{Kauvar2015ConsensusFN,
  title={Consensus for nonmelanoma skin cancer treatment: basal cell carcinoma, including a cost analysis of treatment methods.},
  author={Arielle N. B. Kauvar and Terrence A Cronin and Randall K. Roenigk and GeorgeJ. Hruza and Richard Thomas Bennett},
  journal={Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]},
  year={2015},
  volume={41 5},
  pages={
          550-71
        }
}
BACKGROUND Basal cell carcinoma (BCC) is the most common cancer in the US population affecting approximately 2.8 million people per year. Basal cell carcinomas are usually slow-growing and rarely metastasize, but they do cause localized tissue destruction, compromised function, and cosmetic disfigurement. OBJECTIVE To provide clinicians with guidelines for the management of BCC based on evidence from a comprehensive literature review, and consensus among the authors. MATERIALS AND METHODS… CONTINUE READING
Tweets
This paper has been referenced on Twitter 2 times. VIEW TWEETS

From This Paper

Figures, tables, and topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-10 OF 24 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 142 REFERENCES

Basal cell carcinoma in young women: an evaluation of the association of tanning bed use and smoking

  • AS Boyd, Y Shyr, LE Jr.King
  • J Am Acad Dermatol
  • 2002
Highly Influential
14 Excerpts

Aggressive vs. non-aggressive subtypes (basal cell carcinoma)

  • ME Maloney, SJ Miller
  • Malden: Blackwell Science;
  • 1998
Highly Influential
3 Excerpts

Similar Papers

Loading similar papers…